| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Jan―05 |
Monitoring TB infection in contact cases: the impact of the COVID-19 pandemic |
M. Tyufekchieva, T. Varleva |
| 2 |
[GO] |
2023―Dec―03 |
The impact of COVID-19 on TB care in Brazil |
E. R. D. Neto, T. S. Matos, A. C. Furtado Ferreira, M. Bezerra-Santos, A. G. da Silva Junior, R. F. do Carmo, C. D. F. de Souza |
| 3 |
[GO] |
2023―Aug―23 |
The impact of the COVID-19 pandemic on TB diagnosis in the Brazilian prison population, 2020-2021 |
D. R. do Nascimento, S. F. Serpa, M. Bezerra-Santos, R. F. do Carmo, R. J. V. C. de Brito, O. V. Gomes, A. da Costa Armstrong, C. D. F. de Souza |
| 4 |
[GO] |
2023―Aug―23 |
Meeting of two pandemics in prison: a challenging event in a challenging environment |
M. Feasi, E. Pontali |
| 5 |
[GO] |
2023―Jun―24 |
TB and COVID-19 co-infection in a pulmonology hospital |
A. Głogowska, G. Przybylski, J. Bukowski, E. Dolska, R. Żebracka, D. Krawiecka, E. Augustynowicz-Kopeć |
| 6 |
[GO] |
2023―May―26 |
Prevalence of COVID-19 infection in TB clinics in Kampala, Uganda |
B. Otaalo, M. Cevik, E. Mwebesa, R. Nabisere-Arinaitwe, S. Zawedde-Muyanja, J. Nampala, C. Nanziri, L. Alinaitwe, F. Aber, J. Bayigga, B. Nankinga, E. Laker, N. C. Owarwo, W. Sabiiti, S. Adakun, B. Kirenga, S. Turyahabwe, D. J. Sloan, C. Sekaggya-Wiltshire |
| 7 |
[GO] |
2023―May―05 |
Impact of the COVID-19 pandemic on TB care in Peru |
J. L. Paredes, V. Picon, L. Reynolds, C. Ugarte-Gil, D. Moore |
| 8 |
[GO] |
2023―Mar―01 |
A study of persistent symptoms and pulmonary function at 3 months post moderate or severe COVID-19 in Angola |
W. Dias, M. Silva, C. S. Sebastião, M. Arrais |
| 9 |
[GO] |
2023―Jan―25 |
Co-testing a single sputum specimen for TB and SARS-CoV-2 |
L. P. Genade, T. Kahamba, L. Scott, S. Tempia, S. Walaza, A. David, W. Stevens, K. Hlongwane, A. von Gottberg, M. Du Plessis, J. Kleynhans, C. Cohen, N. A. Martinson |
| 10 |
[GO] |
2023―Jan―12 |
Poor dietary intake at hospital admission is a predictor of mortality in patients with COVID-19 |
S. Zotti, S. Travaglini, P. Finamore, G. Sanson, A. Iollo, S. Emerenziani, C Nuglio, F. Ferravante, R. Nicolò, R. A. Incalzi, S. Scarlata |
| 11 |
[GO] |
2023―Jan―12 |
Impact of the COVID-19 pandemic on the epidemiology of TB in a low-incidence setting |
J. K. Mah, A. Lieu, D. Fisher, R. K. Lim |
| 12 |
[GO] |
2022―Oct―25 |
IGRA test for TB in COVID-19: role of corticosteroids |
B. Granozzi, F. Bisognin, M. Tadolini, G. Lombardi, E. Zangoli, D. Salvi, A. Dormi, P. Dal Monte |
| 13 |
[GO] |
2022―Sep―27 |
Death due to respiratory diseases in children and adolescents in the first wave of COVID-19 |
L. M. L. B. F. Lasmar, M. R. de Carvalho, P. A. N. Campos, G. L. Gonçalves, J. P. F. Ribeiro, J. V. C. de Queiroz, M. V. N. P. de Queiroz |
| 14 |
[GO] |
2022―Sep―27 |
COVID-19 media communications: a new role for health professionals? |
F. Lopes, R. Araújo, G. B. Migliori, R. Duarte |
| 15 |
[GO] |
2022―Sep―27 |
Post-hospitalisation respiratory and physical functions in patients with SARS-CoV-2 delta |
Q. Wu, L. Feng, H. Li, S. Huang, L. Shi, L. Li, H. Li, L. Zhang, F. Yang, Y. Zhang, Q. Wu |
| 16 |
[GO] |
2022―Aug―23 |
Impact of COVID-19 on diagnosis and testing for TB in a high-resource, low-burden setting |
A. J. Jones, E. C. Jones-López, S. M. Butler-Wu, M. L. Wilson, J. Rodman, L. Flors, C. Voyageur, B. E. Jones |
| 17 |
[GO] |
2022―Aug―23 |
The COVID-19 pandemic does not bode well for TB control |
J. Ahmed, R. Bir, K. Bala, U. B. Singh |
| 18 |
[GO] |
2022―Jul―28 |
The COVID-19 and TB syndemic: the way forward |
A. Trajman, I. Felker, L. C. Alves, I. Coutinho, M. Osman, S-A. Meehan, U. B. Singh, Y. Schwartz |
| 19 |
[GO] |
2022―Jul―28 |
TB diagnosis and treatment during the COVID-19 pandemic |
S. Chhabra, C. W. M. Ong, G. Sotgiu |
| 20 |
[GO] |
2022―Jul―12 |
Accelerating TB diagnosis during the COVID-19 pandemic |
T. S. Yee, C. V. Choong, L. E. Wee, K. C. M. Goh, S. J. Wu, K. M. K. Win, C. W. M. Ong, D. H. L. Ng |
| 21 |
[GO] |
2022―Jul―12 |
TB reporting declines in priority countries during the COVID-19 pandemic |
K. Varshney, J. C. Rusnak |
| 22 |
[GO] |
2022―Jul―12 |
Towards meaningful inclusion of people affected by TB: lessons from the COVID-19 response |
A. Versfeld, J. Malar, V. Soltan, B. Kampoer, R. Mburu, C. Nawina, O. Khuat |
| 23 |
[GO] |
2022―Jul―12 |
Down Syndrome and COVID-19: not always a poor prognosis |
A. Parisini, S. Boni, E Blasi Vacca, F. Del Puente, M. Feasi, N. Bobbio, R. Prinapori, C. Bolla, M. Castellaneta, E. Pontali, G. Chichino |
| 24 |
[GO] |
2022―Mar―30 |
COVID-19 effect on TB presentation and outcome |
V. Marchese, B. Formenti, L. Marchese, N. Gregori, G. Gardini, G. Russo, F. Bona, G. Di Rosario, M. Gulletta, L. R. Tomasoni, F. Castelli, A. Matteelli |
| 25 |
[GO] |
2022―Mar―30 |
Impact of COVID-19 on the diagnosis and management of lung cancer and TB |
J. W. Kim, C. Vella, W. Parvez, R. Verma, M. Majid, G. Woltmann, M. Pareek, J. Bennett, S. Agrawal, R. Sudhir, L. Ahyow, M. Tufail, P. Haldar |
| 26 |
[GO] |
2022―Mar―30 |
Transient diaphragmatic thinning in patients with interstitial pneumonia due to SARS-CoV-2 |
S. Battisti, G. Sanson, E. Paolucci, E. Giampalma, E. Russo, C. Bergamini, V. Agnoletti, S. Di Bella, A. Palermo, S. Scarlata |
| 27 |
[GO] |
2022―Feb―24 |
Financial impact of COVID-19 on TB patients in India |
S. Chatterjee, P. Das, A. Vassall |
| 28 |
[GO] |
2022―Feb―24 |
Evaluation of COVID-19 screening for international travellers |
K. Lönnroth, M. Nordberg, M. Grunér, O. Pazhman, J. Nagamori, A. Westermark |
| 29 |
[GO] |
2022―Jan―28 |
Impact of COVID-19 on extrapulmonary TB and the benefit of decentralised TB services |
E. M. Tinoco, A. Vasconcelos, F. Alves, R. Duarte |
| 30 |
[GO] |
2022―Jan―28 |
Decreased notification of TB cases during the COVID-19 pandemic |
Y. Ortiz-Martínez, A. J. Rodríguez-Morales, A. F. Henao-Martínez |
| 31 |
[GO] |
2022―Jan―28 |
Impact of the COVID-19 pandemic on TB infection testing |
V. Schiza, M. Kruse, Y. Xiao, S. Kar, K. Lovejoy, P. Wrighton-Smith, A. Tattersall |
| 32 |
[GO] |
2021―Dec―31 |
Down syndrome and COVID-19, a combination with a poor prognosis |
D. L. Silva, C. M. Lima, V. C. R. Magalhães, L. M. Baltazar, N. T. A. Peres, R. B. Caligiorne, A. S. Moura, T. Fereguetti, J. C. Martins, L. F. Rabelo, A. C. Lyon, S. Johann, D. A. Santos |
| 33 |
[GO] |
2021―Dec―31 |
National TB prevalence surveys in the COVID-19 era |
M. Tadolini, I. Onozaki |
| 34 |
[GO] |
2021―Dec―10 |
Decline in TB incidence during the COVID-19 pandemic |
S. Zamani, M. R. Honarvar, N. Behnampour, M. Sheikhy, M. Sedaghat, S. Ghaemi, E. A. Ghaemi |
| 35 |
[GO] |
2021―Nov―22 |
Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19 |
E. Mohr-Holland, D. Hacking, J. Daniels, V. Scott, V. Mudaly, J. Furin, C. Pfaff, A. Reuter |
| 36 |
[GO] |
2021―Nov―22 |
A roadmap for lifting restrictive measures for COVID-19 |
A. Aguiar, M. Pinto, F. Alves, P. Barbosa, H. Monteiro, J. Bigotte, M. Santos, Ó. Felgueiras, M. Dara, R. Duarte |
| 37 |
[GO] |
2021―Nov―22 |
TB and COVID-19 coinfection |
M. Kozińska, R. Podlasin, K. Ropelewska-Łącka, B. Wojtycha-Kwaśnica, I. Bajera-Mitschein, E. Augustynowicz-Kopeć |
| 38 |
[GO] |
2021―Nov―22 |
Impact of COVID-19 on TB detection in the private sector in Nepal |
R. Sah, U. K. Singh, R. Mainali, N. A. Vasquez, A. Khan |
| 39 |
[GO] |
2021―Nov―22 |
The impact of COVID-19 on the TB response: data from the field |
A. R. Gigante, M. Sousa, A. Aguiar, M. Pinto, R. Gaio, R. Duarte |
| 40 |
[GO] |
2021―Nov―22 |
Non-hospitalised COVID-19 patients have more frequent long COVID-19 symptoms |
A. A. R. Mohamed-Hussein, M. T. Amin, H. A. Makhlouf, N. A. Makhlouf, I. Galal, H. K. Abd-Elaal, D. Abdeltawab, K. M. S. Kholief, M. K. Hashem |
| 41 |
[GO] |
2021―Nov―22 |
COVID-19 vaccine-induced thrombosis |
M. Ambrosetti, E. Pontali |
| 42 |
[GO] |
2021―Nov―22 |
Thrombotic events and COVID-19 vaccines |
C. Brazete, A. Aguiar, I. Furtado, R. Duarte |
| 43 |
[GO] |
2021―Oct―07 |
Impact of COVID-19 on TB epidemiology in South Korea |
H. Choi, Y. Ko, C. Y. Lee, S. J. Chung, H. I. Kim, J-H. Kim, S. Park, Y. I. Hwang, S. H. Jang, K-S. Jung, Y. K. Kim, J. Y. Park |
| 44 |
[GO] |
2021―Oct―07 |
Impact of COVID-19 on hospitalisations for asthma |
L. Zhang, Y. M. Castro, P. Camargos |
| 45 |
[GO] |
2021―Oct―07 |
Inhaled remdesivir treatment for COVID-19 |
C. Yang, H. Zhao |
| 46 |
[GO] |
2021―Jul―31 |
The 100th anniversary of bacille Calmette-Guérin (BCG) and the latest vaccines against COVID-19 |
P. J. G. Bettencourt |
| 47 |
[GO] |
2021―May―29 |
COVID-19 and TB: a progression-regression conundrum |
A. K. J. Teo, C. W. M. Ong, L. Y. Hsu |
| 48 |
[GO] |
2021―May―29 |
The impact of COVID-19 on TB: a review of the data |
C. F. McQuaid, A. Vassall, T. Cohen, K. Fiekert, R. G. White |
| 49 |
[GO] |
2021―May―12 |
Impact of influenza A co-infection with COVID-19 |
A. Agarwal, M. Agarwal, A. Sharma, R. Jakhar |
| 50 |
[GO] |
2021―May―12 |
The Barts Health NHS Trust COVID-19 cohort: characteristics, outcomes and risk scoring of patients in East London |
T. Crocker-Buque, S. Williams, A. R. Brentnall, R. Gabe, S. Duffy, J. R. Prowle, C. Orkin, H. Kunst, T. Cutino-Moguel, D. Zenner, B. Bloom, M. Melzer, S. de Freitas, M. Darmalingam, K. McCafferty, V. Kapil, P. Pfeffer, J. Martin, Y. Gourtsoyannis, S. Chandran, A. Dhariwal, R. Rachman, I. Milligan, D. Mabayoje, E. Adobah, J. Falconer, H. Nugent, M. Yaqoob, D. Collier, R. Pearse, M. Caulfield, S. Tiberi |
| 51 |
[GO] |
2021―May―12 |
Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era |
N. Zokufa, K. Lebelo, D. Hacking, L. Tabo, P. Runeyi, N. Malabi, S. B. Sibanda, T. Cassidy, G. Makanda, B. Norman, S. Khuzani, J. Furin, C. Jonker, B. Nkasana, V. Scott, C. Pfaff |
| 52 |
[GO] |
2021―May―12 |
TB and COVID-19 in migrants - the need to focus on both conditions |
I. Margineanu, Z. Mor, D. Garcia, C. Gilpin, S. Dhawan, N. Ritz, D. Zenner |
| 53 |
[GO] |
2021―May―12 |
Impact of COVID-19 on TB services in Korea |
J. Min, J. Y. Kang, J. Kim, J. Yang, Y. Kwon, E. Shim, H. K. Park, J. S. Kim, S-S. Lee, J. S. Park |
| 54 |
[GO] |
2021―May―12 |
A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients |
E. Mohr-Holland, J. Daniels, B. Douglas-Jones, N. Mema, V. Scott, L. Trivino-Duran, C. Pfaff, J. Furin, P. Isaakidis |
| 55 |
[GO] |
2021―Mar―25 |
TB and COVID-19: measuring key risk factors that affect treatment outcomes |
A. D. Harries, A. M. V. Kumar, S. Satyanarayana, P. Thekkur, Y. Lin, R. A. Dlodlo, G. Brigden |
| 56 |
[GO] |
2021―Mar―10 |
Tobacco use and quitting behaviour during COVID-19 lockdown |
S. Veeraiah, R. Sudhakar, J. P. Tripathy, D. Sankar, A. Usharani, S. Ramakrishnan, J. Selvam, G. Nagarajan, D. S. Prabhakar, R. Swaminathan |
| 57 |
[GO] |
2021―Mar―10 |
TB research amidst the COVID-19 pandemic |
D. S. Graciaa, R. R. Kempker, E. Sanikidze, S. Tukvadze, L. Mikiashvili, R. Aspindzelashvili, D. Alkhazashvili, H. M. Blumberg, Z. Avaliani, N. Tukvadze |
| 58 |
[GO] |
2021―Feb―18 |
Changes to TB care in an outpatient centre during the COVID-19 pandemic |
A. Aguiar, I. Furtado, M. Sousa, M. Pinto, R. Duarte |
| 59 |
[GO] |
2021―Feb―18 |
Increase in disseminated TB during the COVID-19 pandemic |
J. Barrett, H. Painter, A. Rajgopal, D. Keane, L. John, P. Papineni, A. Whittington |
| 60 |
[GO] |
2021―Feb―18 |
Treatment outcomes for COVID-19: a prospective cohort study |
Z. Bao, J. Liu, Y. Hu, Y. Li, B. Gu, J. Zhu, X. Zheng, M. Wu, X. Shen, J. W. Alffenaar |
| 61 |
[GO] |
2021―Jan―01 |
TB and COVID-19 co-infection: rationale and aims of a global study |
The TB/COVID-19 Global Study Group |
| 62 |
[GO] |
2021―Jan―01 |
Continuity of TB services during the COVID-19 pandemic in China |
X. Shen, W. Sha, C. Yang, Q. Pan, T. Cohen, S. Cheng, Q. Cai, X. Kan, P. Zong, Z. Zeng, S. Tan, R. Liang, L. Bai, J. Xia, S. Wu, P. Sun, G. Wu, C. Cai, X. Wang, K. Ai, J. Liu, Z. Yuan |
| 63 |
[GO] |
2020―Dec―15 |
Two parallel pandemics: the challenges faced by countries with COVID-19 and TB |
J. Singh, N. Z. Ehtesham, S. E. Hasnain |
| 64 |
[GO] |
2020―Dec―15 |
The impact of COVID-19 on the diagnosis of TB in Taiwan |
J.-L. Fang, C.-M. Chao, H.-J. Tang |
| 65 |
[GO] |
2020―Nov―11 |
Resource reprioritisation amid competing health risks for TB and COVID-19 |
S. Zhou, Q. Van Staden, E. Toska |
| 66 |
[GO] |
2020―Nov―11 |
In Reply: How TB and COVID-19 compare: an opportunity to integrate both control programmes |
R. Fatima, A. Yaqoob |
| 67 |
[GO] |
2020―Nov―11 |
Impact of COVID-19 on patients with asthma |
P. Pignatti, D. Visca, F. Cherubino, E. Zampogna, A. Spanevello |
| 68 |
[GO] |
2020―Nov―11 |
Impact of COVID-19 on TB diagnosis in Northeastern Brazil |
C. D. F. de Souza, H. S. Coutinho, M. M. Costa, M. A. F. M. Magalhães, R. F. Carmo |
| 69 |
[GO] |
2020―Nov―11 |
Impact of shelter-in-place on TB case notifications and mortality during the COVID-19 pandemic |
J. L. Kadota, T. F. Reza, T. Nalugwa, A. Kityamuwesi, G. Nanyunja, N. Kiwanuka, P. Shete, J. L. Davis, D. Dowdy, S. Turyahabwe, A. Katamba, A. Cattamanchi |
| 70 |
[GO] |
2020―Oct―31 |
How to manage children if a second wave of COVID-19 occurs |
S. Esposito, S. Zona, G. Vergine, M. Fantini, F. Marchetti, M. Stella, E. Valletta, G. Biasucci, M. Lanari, I. Dodi, M. Bigi, A. M. Magista, F. Vaienti, A. Cella, P. Affanni, M. C. Re, V. Sambri, N. Principi |
| 71 |
[GO] |
2020―Oct―31 |
Adapting TB services during the COVID-19 pandemic in Mumbai, India |
A. C Meneguim, L. Rebello, M. Das, S. Ravi, T. Mathur, S. Mankar, S. Kharate, P. Tipre, V. Oswal, A. Iyer, H. Mansoor, S. Kalon, D. Garone, G. Ferlazzo, P. Isaakidis |
| 72 |
[GO] |
2020―Oct―31 |
Impact of the COVID-19 pandemic on the detection of TB in Shanghai, China |
Z. Wu, J. Chen, Z. Xia, Q. Pan, Z. Yuan, W. Zhang, X. Shen |
| 73 |
[GO] |
2020―Oct―31 |
TB and the COVID-19 pandemic: brothers in arms against lung health |
R. Shahriarirad, M. J. Fallahi |
| 74 |
[GO] |
2020―Oct―31 |
Disease progression in patients with COVID-19: a retrospective cohort study in China |
H. Luo, S. Liu, Y. Wang, K. Mortimer, S. Ju, Y. Yang, D. Wang |
| 75 |
[GO] |
2020―Oct―10 |
COVID-19 and TB control in immigrant communities |
F. A. Wilson, T. L. Miller, J. P. Stimpson |
| 76 |
[GO] |
2020―Oct―10 |
How COVID-19 can instruct TB research: ensuring the safety of researchers exposed to infectious disease |
M. van der Walt, K. H. Keddy |
| 77 |
[GO] |
2020―Oct―10 |
How TB and COVID-19 compare: an opportunity to integrate both control programmes |
G. Echeverría, W. Espinoza, J.H. de Waard |
| 78 |
[GO] |
2020―Oct―10 |
Impact of COVID-19 on TB care: experiences of a treatment centre in Nigeria |
O. O. Adewole |
| 79 |
[GO] |
2020―Sep―11 |
Effect of chronic obstructive pulmonary disease and smoking on the outcome of COVID-19 |
R. Pranata, A. Y. Soeroto, I. Huang, M. A. Lim, P. Santoso, H. Permana, A. A. Lukito |
| 80 |
[GO] |
2020―Sep―11 |
COVID-19 and tuberculosis-threats and opportunities |
Alimuddin Zumla, B. J. Marais, T. D. McHugh, M. Maeurer, Adam Zumla, N. Kapata, F. Ntoumi, P. Chanda-Kapata, S. Mfinanga, R. Centis, D. M. Cirillo, E. Petersen, D. S Hui, G. Ippolito, C. C. Leung, G. B. Migliori, S. Tiberi |
| 81 |
[GO] |
2020―Sep―11 |
COVID-19 in Africa: community and digital technologies for tuberculosis management |
K. G. Koura, A. D. Harries, P. I. Fujiwara, R. A Dlodlo, E. K. Sansan, B. Kampoer, D. Affolabi, A. Combary, V. Mbassa, H. Gando, A. Bangoura, M. Assao, B. Gning, M. F. Dogo, A. Fiogbé, G. Bridgen |
| 82 |
[GO] |
2020―Sep―11 |
Spatial variability in the risk of death from COVID-19 in Italy |
K. Mizumoto, S. Dahal, G. Chowell |
| 83 |
[GO] |
2020―Sep―11 |
A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic |
J. K. Louie, M. Reid, J. Stella, R. Agraz-Lara, S. Graves, L. Chen, P. Hopewell |
| 84 |
[GO] |
2020―Sep―11 |
Responding to COVID-19: adjusting TB services in a low-burden setting |
K. Watts, A. McKeown, J. Denholm, A. M. Baker |
| 85 |
[GO] |
2020―Sep―11 |
COVID-19: ensuring continuity of TB services in the private sector |
W. Z. Jamal, S. Habib, S. Khowaja, N. Safdar, S. M. A. Zaidi |
| 86 |
[GO] |
2020―Jul―28 |
Severe COVID-19 cases with a history of active or latent tuberculosis |
C. Liu, Y. Yu, J. Fleming, T. Wang, S. Shen, Y. Wang, L. Fan, J. Ma, Y. Gu, Y. Chen |
| 87 |
[GO] |
2020―Jul―28 |
COVID-19 in Africa: preparing for the storm |
J. Chakaya, A. Binegdie, A. Irungu, B. Pearson, D. Gray, H. J. Zar, I. Schewitz, J. Kagima, K. Mortimer, O. B. Ozoh, R. Masekela, S. B. Gordon, W. Worodria, J. Aluoch |
| 88 |
[GO] |
2020―Jul―28 |
Common concerns in managing bronchial asthma during the COVID-19 pandemic |
C-S. Chai, C-K. Liam |
| 89 |
[GO] |
2020―Jul―28 |
Transforming essential services for tuberculosis during the COVID-19 pandemic: lessons from New York City |
J. Burzynski, M. Macaraig, D. Nilsen, N. W. Schluger |
| 90 |
[GO] |
2020―Jul―28 |
Bacille Calmette-Guérin (BCG) vaccine and the COVID-19 pandemic: responsible stewardship is needed |
H. S. Schaaf, K. du Preez, M. Kruger, R. Solomons, J. J. Taljaard, H. Rabie, J. A. Seddon, M. F. Cotton, M. Tebruegge, N. Curtis, A. C. Hesseling |
| 91 |
[GO] |
2020―Jun―18 |
Face masks - a sustainable measure to mitigate COVID-19 |
S. K. Jindal, A. N. Aggarwal, D. J. Christopher, R. Dhar, A. Jindal |
| 92 |
[GO] |
2020―Jun―18 |
Successful treatment of patients severely ill with COVID-19 |
Z. Bao, B. Gu, J. Liu, J. Zhu, J-W. Alffenaar, Y. Hu, X. Shen |
| 93 |
[GO] |
2020―Jun―18 |
Mask wearing to complement social distancing and save lives during COVID-19 |
C. C. Leung, K. K. Cheng, T. H. Lam, G. B. Migliori |
| 94 |
[GO] |
2020―Jun―18 |
Preparing national tuberculosis control programmes for COVID-19 |
C. Sandy, K. C. Takarinda, C. Timire, H. Mutunzi, M. Dube, R. A. Dlodlo, A. D. Harries |
| 95 |
[GO] |
2020―Jun―18 |
How to demystify COVID-19 and reduce social stigma |
G. Sotgiu, G. Carta, L. Suelzu, D. Carta, G B. Migliori |
| 96 |
[GO] |
2020―Jun―18 |
Collaboration in TB and COVID-19 control in Moscow |
E. Bogorodckaya, M. Sinitsyn, S. Borisov |
| 97 |
[GO] |
2020―Jun―18 |
Serology-positive but minimally symptomatic COVID-19 may still cause lung injury and lung function impairment |
J-Y. Wang, S-Y. Chang, Y-W. Huang, S-C. Chang |
| 98 |
[GO] |
2020―Jun―18 |
Impact of COVID-19 on tuberculosis services in India |
A. Gupta, R. Singla, J. A. Caminero, N. Singla, P. Mrigpuri, A. Mohan |
| 99 |
[GO] |
2020―Jun―18 |
Sustaining essential healthcare in Africa during the COVID-19 pandemic |
J. J. Ongole, T. M. Rossouw, P. Bernard Fourie, A. C. Stoltz, J. Hugo, T. S. Marcus |
| 100 |
[GO] |
2020―Jun―18 |
Helping Africa to breathe when COVID-19 strikes |
P. M. Fenton |
| 101 |
[GO] |
2020―Jun―18 |
Concern over a COVID-19-related BCG shortage |
H. Namkoong, N. Horita, R. Ebina-Shibuya |
| 102 |
[GO] |
2020―Jun―18 |
Predictive models for COVID-19-related deaths and infections |
A.G. Gerli, S. Centanni, M. Miozzo, G. Sotgiu |
| 103 |
[GO] |
2020―May―13 |
Adapting a TB contact investigation strategy for COVID-19 |
T-A. Nguyen, Q. N. Cuong, A. L. T. Kim, T. N. Huong, H. N. Nguyen, G. J. Fox, G. B. Marks |
| 104 |
[GO] |
2020―May―13 |
Tackling the threat of COVID-19 in Africa: an urgent need for practical planning |
C-Y. Chiang, A. El Sony |
| 105 |
[GO] |
2020―May―13 |
Impact of COVID-19 on tuberculosis control in China |
Y. Pang, Y. Liu, J. Du, J. Gao, L. Li |
| 106 |
[GO] |
2020―May―13 |
Impact of the global COVID-19 outbreak on the management of other communicable diseases |
C. W. M. Ong, D. Goletti |
| 107 |
[GO] |
2020―May―13 |
Critical changes to services for TB patients during the COVID-19 pandemic |
V. Cox, L. Wilkinson, A. Grimsrud, J. Hughes, A. Reuter, F. Conradie, J. Nel, T. Boyles |
| 108 |
[GO] |
2020―May―13 |
Monitoring the COVID-19 pandemic in sub-Saharan Africa: focusing on health facility admissions and deaths |
A. D. Harries, L. Martinez, J. M. Chakaya |
| 109 |
[GO] |
2020―May―13 |
New diseases and old threats: lessons from tuberculosis for the COVID-19 response |
M. Dara, G. Sotgiu, M. R. Reichler, C-Y. Chiang, C. B. E. Chee, G. B. Migliori |
| 110 |
[GO] |
2020―Apr―22 |
Let us not forget the mask in our attempts to stall the spread of COVID-19 |
C. C. Leung, T. H. Lam, K. K. Cheng |
|
